News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
312,543 Results
Type
Article (22103)
Company Profile (25)
Press Release (290408)
Multimedia
Podcasts (59)
Webinars (6)
Section
Business (74283)
Career Advice (446)
Deals (11808)
Drug Delivery (41)
Drug Development (75065)
Employer Resources (47)
FDA (8761)
Job Trends (6157)
News (165785)
Policy (15063)
Tag
Academia (1105)
Accelerated approval (28)
Adcomms (32)
Allergies (107)
Alliances (19897)
ALS (149)
Alzheimer's disease (1453)
Antibody-drug conjugate (ADC) (260)
Approvals (8967)
Artificial intelligence (269)
Autoimmune disease (116)
Automation (9)
Bankruptcy (108)
Best Places to Work (5451)
BIOSECURE Act (10)
Biosimilars (94)
Biotechnology (25)
Bladder cancer (147)
Brain cancer (56)
Breast cancer (529)
Cancer (3992)
Cardiovascular disease (319)
Career advice (408)
Career pathing (10)
CAR-T (231)
CDC (5)
Celiac Disease (1)
Cell therapy (562)
Cervical cancer (27)
Clinical research (67062)
Collaboration (884)
Company closure (3)
Compensation (385)
Complete response letters (52)
COVID-19 (1997)
CRISPR (47)
C-suite (394)
Cystic fibrosis (96)
Data (5308)
Decentralized trials (2)
Denatured (19)
Depression (121)
Diabetes (356)
Diagnostics (2191)
Digital health (17)
Diversity (10)
Diversity, equity & inclusion (15)
Drug discovery (135)
Drug pricing (43)
Drug shortages (4)
Duchenne muscular dystrophy (186)
Earnings (33943)
Editorial (27)
Employer branding (5)
Employer resources (44)
Events (46913)
Executive appointments (461)
FDA (10999)
Fibrodysplasia Ossificans Progressiva (4)
Friedreich's ataxia (8)
Frontotemporal dementia (19)
Funding (868)
Gene editing (123)
Generative AI (29)
Gene therapy (443)
GLP-1 (713)
Government (1972)
Grass and pollen (4)
Guidances (211)
Healthcare (7479)
HIV (37)
Huntington's disease (44)
IgA nephropathy (81)
Immunology and inflammation (212)
Immuno-oncology (48)
Indications (82)
Infectious disease (2165)
Inflammatory bowel disease (138)
Inflation Reduction Act (2)
Influenza (74)
Intellectual property (157)
Interviews (80)
IPO (6682)
IRA (14)
Job creations (991)
Job search strategy (341)
JPM (34)
Kidney cancer (16)
Labor market (16)
Layoffs (296)
Leadership (12)
Legal (2325)
Liver cancer (75)
Longevity (9)
Lung cancer (561)
Lymphoma (336)
Machine learning (25)
Management (19)
Manufacturing (333)
MASH (154)
Medical device (4363)
Medtech (4381)
Mergers & acquisitions (5632)
Metabolic disorders (959)
Multiple sclerosis (133)
NASH (20)
Neurodegenerative disease (264)
Neuropsychiatric disorders (83)
Neuroscience (2474)
Neurotech (1)
NextGen: Class of 2026 (2011)
Non-profit (1371)
Now hiring (14)
Obesity (434)
Opinion (165)
Ovarian cancer (152)
Pain (157)
Pancreatic cancer (203)
Parkinson's disease (253)
Partnered (16)
Patents (294)
Patient recruitment (468)
Peanut (48)
People (20790)
Pharmaceutical (8)
Pharmacy benefit managers (5)
Phase 1 (20973)
Phase 2 (29796)
Phase 3 (22497)
Pipeline (3827)
Policy (90)
Postmarket research (1903)
Preclinical (5923)
Press Release (12)
Prostate cancer (197)
Psychedelics (45)
Radiopharmaceuticals (207)
Rare diseases (640)
Real estate (1538)
Recruiting (14)
Regulatory (13933)
Reports (18)
Research institute (1317)
Resumes & cover letters (42)
Rett syndrome (26)
RNA editing (10)
RSV (49)
Schizophrenia (135)
Series A (131)
Series B (132)
Service/supplier (3)
Sickle cell disease (62)
Special edition (9)
Spinal muscular atrophy (141)
Sponsored (25)
Startups (1399)
Stomach cancer (13)
Supply chain (35)
Tariffs (14)
The Weekly (40)
Vaccines (691)
Venture capital (45)
Weight loss (267)
Women's health (53)
Worklife (8)
Date
Last 7 days (321)
Last 30 days (1232)
Last 365 days (18643)
2026 (1651)
2025 (18926)
2024 (21051)
2023 (23353)
2022 (26763)
2021 (28227)
2020 (25244)
2019 (18497)
2018 (13950)
2017 (16178)
2016 (14224)
2015 (17060)
2014 (11401)
2013 (8504)
2012 (9025)
2011 (9372)
2010 (8873)
Location
Africa (308)
Alabama (61)
Alaska (3)
Arizona (94)
Arkansas (4)
Asia (21646)
Australia (4624)
California (6773)
Canada (1754)
China (806)
Colorado (239)
Connecticut (285)
Delaware (223)
Europe (45720)
Florida (965)
Georgia (235)
Hawaii (1)
Idaho (19)
Illinois (341)
India (30)
Indiana (318)
Iowa (9)
Japan (291)
Kansas (51)
Kentucky (20)
Louisiana (6)
Maine (9)
Maryland (762)
Massachusetts (4854)
Michigan (136)
Minnesota (253)
Mississippi (2)
Missouri (57)
Montana (26)
Nebraska (8)
Nevada (67)
New Hampshire (26)
New Jersey (1941)
New Mexico (13)
New York (1999)
North Carolina (819)
Northern California (3344)
Ohio (183)
Oklahoma (7)
Oregon (24)
Pennsylvania (1309)
Puerto Rico (14)
Rhode Island (9)
South America (318)
South Carolina (16)
Southern California (2701)
Tennessee (88)
Texas (1071)
United States (23522)
Utah (126)
Virginia (140)
Washington D.C. (43)
Washington State (639)
West Virginia (2)
Wisconsin (42)
312,543 Results for "transperfect trial interactive".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Business
Gedeon Richter Selects Trial Interactive for Clinical Trial Management
TransPerfect Life Sciences, a leading global provider of solutions for product development and launch for the biopharmaceutical industry, announced that Gedeon Richter selected Trial Interactive’s award-winning eTMF platform and TI Collaborate eClinical solution for its upcoming clinical trials.
March 25, 2024
·
3 min read
Press Releases
Lightship Inc. Acquires Veda Trials to Expand Community-Based Clinical Research Delivery
The acquisition expands scalable trial operations across real-world care settings
February 4, 2026
·
1 min read
Podcast
Roche Makes Obesity Splash, Moderna Cans Vaccine Trials, Sarepta’s New Data, More
Roche’s obesity candidate achieves 22.5% weight loss in Phase II; Moderna pulls the plug on late-stage vaccine trials as Health Secretary Robert F. Kennedy’s anti-vaccine policies and rhetoric continues; and embattled gene therapy maker Sarepta announces new data in Duchenne muscular dystrophy.
January 28, 2026
·
1 min read
·
Heather McKenzie
Regulatory
FDA’s ‘Conundrum’: What To Do With Approved Drugs That Fail Pivotal or Confirmatory Trials
With notable therapies from Biogen, Sarepta and MacroGenics failing to show efficacy in pivotal or confirmatory trials, experts question the use of biomarker evidence for approval while one former regulator insists that a “failed trial is not a failed drug.”
December 15, 2025
·
7 min read
·
Heather McKenzie
IN PARTNERSHIP WITH TAKEDA
Takeda’s Commitment to Trial Representation is Shaping the Future of Clinical Research
One way Takeda lives out its values is by striving to ensure that patients are aware of and can access the company’s clinical trials. Two employees from its research and development organization discuss why representation matters and the work their team is doing to benefit patients now and in the future.
January 5, 2026
·
5 min read
·
BioSpace Insights
Depression
5 Depression Trials That Failed in 2025
The R&D pipeline for depression therapies faced a demoralizing 2025 as five high-profile candidates, including KOR antagonists by Johnson & Johnson and Neumora Therapeutics, flunked late-stage clinical trials, underscoring the persistent challenges of CNS drug development.
December 8, 2025
·
6 min read
·
Ben Hargreaves
Pharm Country
TransPerfect Life Sciences and Innovaderm Research Expand Trial Interactive Partnership
TransPerfect Life Sciences, a leading provider of services and technologies to support global clinical trials and product development for the biopharmaceutical industry, today announced that Innovaderm will scale their implementation of Trial Interactive to further enable and optimize remote clinical operations.
February 15, 2022
·
4 min read
Press Releases
Cardiol Therapeutics Achieves Key 50% Patient Enrollment Milestone in Pivotal Phase III MAVERIC Trial in Recurrent Pericarditis
• Clinical trial infrastructure fully operational in the U.S. with more than 15 leading cardiovascular centers actively enrolling patients. • Activation of additional top-tier clinical sites in Europe and Canada underway, further accelerating enrollment momentum. • Full enrollment expected in Q2 2026.
January 13, 2026
·
7 min read
Regulatory
In Change That Pushed Pazdur Out, FDA May Lower Clinical Trial Requirements
Commissioner Marty Makary said that the FDA will soon start requiring only one pivotal trial, instead of two, for companies seeking approval for new drugs.
December 5, 2025
·
2 min read
·
Dan Samorodnitsky
Press Releases
BioCytics Successfully Completes a Key Regulatory Milestone with Recent FDA INTERACT Meeting
November 19, 2025
·
2 min read
1 of 31,255
Next
